WVC-16033-14980
3 vaccinations
1 coded response
30 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 840 / UT
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-06
Dose 2 — Pfizer-BioNTech
- 2021-02-06
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-08
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2021-02-10
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-13
- 2021-03-20
- 2021-05-10
- 2021-08-09
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-14
- 2021-12-15
- 2021-12-19
- 2021-12-24
- 2022-01-16
- 2022-01-21
-
2022-03-11
Survey response — 3 months, dose 3MedDRA: Postpartum haemorrhage — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Postpartum hemorrhageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-11 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Postpartum hemorrhage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Postpartum haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release